Literature DB >> 7648684

Recent advances in the molecular genetics of hypertrophic cardiomyopathy.

A J Marian1, R Roberts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7648684     DOI： 10.1161/01.cir.92.5.1336

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  38 in total

Review 1.  Molecular genetics of cardiomyopathies.

Authors:  G Shah; R Roberts
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

Review 2.  Molecular biology of human arrhythmias: implications for the clinical electrophysiologist.

Authors:  N A Estes; M E Mendelsohn
Journal:  J Interv Card Electrophysiol       Date:  1998-12       Impact factor: 1.900

3.  The electrocardiogram as a diagnostic tool for hypertrophic cardiomyopathy: revisited.

Authors:  B J Maron
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-10       Impact factor: 1.468

Review 4.  Athlete"s heart and hypertrophic cardiomyopathy.

Authors:  A Pelliccia
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 2.931

Review 5.  Genetics of cardiovascular disease with emphasis on atrial fibrillation.

Authors:  R Brugada; J Brugada; R Roberts
Journal:  J Interv Card Electrophysiol       Date:  1999-03       Impact factor: 1.900

6.  The locus of a novel gene responsible for arrhythmogenic right-ventricular dysplasia characterized by early onset and high penetrance maps to chromosome 10p12-p14.

Authors:  D Li; F Ahmad; M J Gardner; D Weilbaecher; R Hill; A Karibe; O Gonzalez; T Tapscott; G P Sharratt; L L Bachinski; R Roberts
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

Review 7.  Mandatory ECG screening of athletes: is this question now resolved?

Authors:  Roy J Shephard
Journal:  Sports Med       Date:  2011-12-01       Impact factor: 11.136

8.  Midregional pro-atrial natriuretic peptide: a novel marker of myocardial fibrosis in patients with hypertrophic cardiomyopathy.

Authors:  Elif Elmas; Christina Doesch; Stephan Fluechter; Miriam Freundt; Christel Weiss; Siegfried Lang; Thorsten Kälsch; Dariush Haghi; Jana Papassotiriou; Jan Kunde; Stefan O Schoenberg; Martin Borggrefe; Theano Papavassiliu
Journal:  Int J Cardiovasc Imaging       Date:  2010-09-26       Impact factor: 2.357

9.  Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation.

Authors:  Talita M Marin; Kimberly Keith; Benjamin Davies; David A Conner; Prajna Guha; Demetrios Kalaitzidis; Xue Wu; Jessica Lauriol; Bo Wang; Michael Bauer; Roderick Bronson; Kleber G Franchini; Benjamin G Neel; Maria I Kontaridis
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

10.  Mitochondrial fission is required for cardiomyocyte hypertrophy mediated by a Ca2+-calcineurin signaling pathway.

Authors:  Christian Pennanen; Valentina Parra; Camila López-Crisosto; Pablo E Morales; Andrea Del Campo; Tomás Gutierrez; Pablo Rivera-Mejías; Jovan Kuzmicic; Mario Chiong; Antonio Zorzano; Beverly A Rothermel; Sergio Lavandero
Journal:  J Cell Sci       Date:  2014-04-28       Impact factor: 5.285
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.